Article ID Journal Published Year Pages File Type
2154609 Nuclear Medicine and Biology 2008 5 Pages PDF
Abstract

IntroductionA potential single-photon emission computed tomography imaging agent for labeling of Aβ plaques of Alzheimer's disease, IMPY (2-(4′-dimethylaminophenyl)-6-iodo-imidazo[1,2-a]pyridine), would be effective in detection of prion amyloid deposits in transmissible spongiform encephalopathies (TSEs).MethodsIn vitro autoradiographic studies were carried out with [125I]IMPY on brain sections from scrapie-infected mice and age-matched controls. Competition study was performed to evaluate the prion deposit binding specificity with nonradioactive IMPY.ResultsBinding of [125I]IMPY was observed in infected brain sections, while on age-matched control brain sections, there was no or very low labeling. Prion deposit binding was confirmed by histoblots with prion protein-specific monoclonal antibody 2D6. In the presence of nonradioactive IMPY, the binding of [125I]IMPY was significantly inhibited in all regions studied.ConclusionsThese findings indicate that IMPY can detect the prion deposits in vitro in scrapie-infected mice. Labeled with 123I, this ligand may be useful to quantitate prion deposit burdens in TSEs by in vivo imaging.

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, , , , , , , , ,